nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemfibrozil—CYP1A2—Carmustine—melanoma	0.175	0.27	CbGbCtD
Gemfibrozil—CYP1A2—Vemurafenib—melanoma	0.139	0.213	CbGbCtD
Gemfibrozil—CYP3A4—Temozolomide—melanoma	0.132	0.204	CbGbCtD
Gemfibrozil—CYP1A2—Dacarbazine—melanoma	0.106	0.163	CbGbCtD
Gemfibrozil—CYP3A4—Vemurafenib—melanoma	0.0726	0.112	CbGbCtD
Gemfibrozil—CYP3A4—Docetaxel—melanoma	0.0249	0.0383	CbGbCtD
Gemfibrozil—Vasculitis—Vemurafenib—melanoma	0.00378	0.0173	CcSEcCtD
Gemfibrozil—Reaction gastrointestinal—Docetaxel—melanoma	0.00376	0.0172	CcSEcCtD
Gemfibrozil—Musculoskeletal pain—Vemurafenib—melanoma	0.00374	0.0171	CcSEcCtD
Gemfibrozil—Cerebral haemorrhage—Carmustine—melanoma	0.00353	0.0161	CcSEcCtD
Gemfibrozil—Cerebral haemorrhage—Temozolomide—melanoma	0.00341	0.0156	CcSEcCtD
Gemfibrozil—Myasthenia—Carmustine—melanoma	0.00311	0.0142	CcSEcCtD
Gemfibrozil—Photosensitivity—Vemurafenib—melanoma	0.00305	0.014	CcSEcCtD
Gemfibrozil—Hyperaesthesia—Bleomycin—melanoma	0.00285	0.0131	CcSEcCtD
Gemfibrozil—Atrial fibrillation—Vemurafenib—melanoma	0.00283	0.013	CcSEcCtD
Gemfibrozil—Myopathy—Temozolomide—melanoma	0.00269	0.0123	CcSEcCtD
Gemfibrozil—Hyperaesthesia—Temozolomide—melanoma	0.0024	0.011	CcSEcCtD
Gemfibrozil—Eosinophilia—Vemurafenib—melanoma	0.00229	0.0105	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Vemurafenib—melanoma	0.00211	0.00968	CcSEcCtD
Gemfibrozil—Drug interaction—Carmustine—melanoma	0.0021	0.00964	CcSEcCtD
Gemfibrozil—Weight decreased—Vemurafenib—melanoma	0.0021	0.0096	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Vemurafenib—melanoma	0.00202	0.00927	CcSEcCtD
Gemfibrozil—Musculoskeletal pain—Temozolomide—melanoma	0.00191	0.00875	CcSEcCtD
Gemfibrozil—Phosphatase alkaline increased—Temozolomide—melanoma	0.00189	0.00864	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Vemurafenib—melanoma	0.00182	0.00834	CcSEcCtD
Gemfibrozil—Eye disorder—Vemurafenib—melanoma	0.00173	0.00793	CcSEcCtD
Gemfibrozil—Neuritis—Docetaxel—melanoma	0.00168	0.0077	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Vemurafenib—melanoma	0.00167	0.00765	CcSEcCtD
Gemfibrozil—Alopecia—Vemurafenib—melanoma	0.00164	0.0075	CcSEcCtD
Gemfibrozil—Dysgeusia—Vemurafenib—melanoma	0.00158	0.00724	CcSEcCtD
Gemfibrozil—Blood alkaline phosphatase increased—Temozolomide—melanoma	0.00157	0.00721	CcSEcCtD
Gemfibrozil—Dermatitis exfoliative—Temozolomide—melanoma	0.00145	0.00665	CcSEcCtD
Gemfibrozil—Cough—Vemurafenib—melanoma	0.00141	0.00645	CcSEcCtD
Gemfibrozil—Liver function test abnormal—Dactinomycin—melanoma	0.0014	0.0064	CcSEcCtD
Gemfibrozil—Arthralgia—Vemurafenib—melanoma	0.00137	0.00629	CcSEcCtD
Gemfibrozil—Myalgia—Vemurafenib—melanoma	0.00137	0.00629	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00136	0.00625	CcSEcCtD
Gemfibrozil—Drug interaction—Docetaxel—melanoma	0.00135	0.00619	CcSEcCtD
Gemfibrozil—Pancytopenia—Bleomycin—melanoma	0.00133	0.0061	CcSEcCtD
Gemfibrozil—Blood bilirubin increased—Docetaxel—melanoma	0.00133	0.00607	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Vemurafenib—melanoma	0.00132	0.00603	CcSEcCtD
Gemfibrozil—Liver function test abnormal—Carmustine—melanoma	0.00131	0.00599	CcSEcCtD
Gemfibrozil—Nervous system disorder—Vemurafenib—melanoma	0.00129	0.00592	CcSEcCtD
Gemfibrozil—Skin disorder—Vemurafenib—melanoma	0.00128	0.00586	CcSEcCtD
Gemfibrozil—Weight decreased—Bleomycin—melanoma	0.00127	0.00581	CcSEcCtD
Gemfibrozil—Phosphatase alkaline increased—Docetaxel—melanoma	0.00125	0.00575	CcSEcCtD
Gemfibrozil—Muscular weakness—Carmustine—melanoma	0.00125	0.00572	CcSEcCtD
Gemfibrozil—Pancytopenia—Dactinomycin—melanoma	0.00124	0.00569	CcSEcCtD
Gemfibrozil—Breast disorder—Temozolomide—melanoma	0.00124	0.00567	CcSEcCtD
Gemfibrozil—Muscular weakness—Temozolomide—melanoma	0.00121	0.00553	CcSEcCtD
Gemfibrozil—Colitis—Docetaxel—melanoma	0.0012	0.00552	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Vemurafenib—melanoma	0.0012	0.0055	CcSEcCtD
Gemfibrozil—Pancytopenia—Carmustine—melanoma	0.00116	0.00533	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Vemurafenib—melanoma	0.00114	0.00521	CcSEcCtD
Gemfibrozil—Fatigue—Vemurafenib—melanoma	0.00114	0.0052	CcSEcCtD
Gemfibrozil—Constipation—Vemurafenib—melanoma	0.00113	0.00516	CcSEcCtD
Gemfibrozil—Pancytopenia—Temozolomide—melanoma	0.00112	0.00515	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Bleomycin—melanoma	0.00112	0.00512	CcSEcCtD
Gemfibrozil—Erectile dysfunction—Temozolomide—melanoma	0.00109	0.00499	CcSEcCtD
Gemfibrozil—Depression—Carmustine—melanoma	0.00109	0.00499	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Temozolomide—melanoma	0.00108	0.00495	CcSEcCtD
Gemfibrozil—Renal failure—Carmustine—melanoma	0.00107	0.00492	CcSEcCtD
Gemfibrozil—Weight decreased—Temozolomide—melanoma	0.00107	0.0049	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Carmustine—melanoma	0.00107	0.0049	CcSEcCtD
Gemfibrozil—Urinary tract infection—Carmustine—melanoma	0.00106	0.00486	CcSEcCtD
Gemfibrozil—Depression—Temozolomide—melanoma	0.00105	0.00482	CcSEcCtD
Gemfibrozil—Blood alkaline phosphatase increased—Docetaxel—melanoma	0.00105	0.0048	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Temozolomide—melanoma	0.00103	0.00474	CcSEcCtD
Gemfibrozil—Urinary tract infection—Temozolomide—melanoma	0.00103	0.0047	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Temozolomide—melanoma	0.000998	0.00457	CcSEcCtD
Gemfibrozil—Alopecia—Bleomycin—melanoma	0.000993	0.00455	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Carmustine—melanoma	0.000976	0.00447	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Carmustine—melanoma	0.000964	0.00441	CcSEcCtD
Gemfibrozil—Atrial fibrillation—Docetaxel—melanoma	0.000961	0.0044	CcSEcCtD
Gemfibrozil—Asthenia—Vemurafenib—melanoma	0.000945	0.00433	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Temozolomide—melanoma	0.000943	0.00432	CcSEcCtD
Gemfibrozil—Pruritus—Vemurafenib—melanoma	0.000932	0.00427	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Temozolomide—melanoma	0.000931	0.00426	CcSEcCtD
Gemfibrozil—Alopecia—Dactinomycin—melanoma	0.000926	0.00424	CcSEcCtD
Gemfibrozil—Eye disorder—Carmustine—melanoma	0.000916	0.0042	CcSEcCtD
Gemfibrozil—Anaemia—Bleomycin—melanoma	0.000904	0.00414	CcSEcCtD
Gemfibrozil—Diarrhoea—Vemurafenib—melanoma	0.000901	0.00413	CcSEcCtD
Gemfibrozil—Eye disorder—Temozolomide—melanoma	0.000886	0.00405	CcSEcCtD
Gemfibrozil—Leukopenia—Bleomycin—melanoma	0.000875	0.00401	CcSEcCtD
Gemfibrozil—Dizziness—Vemurafenib—melanoma	0.000871	0.00399	CcSEcCtD
Gemfibrozil—Alopecia—Carmustine—melanoma	0.000866	0.00397	CcSEcCtD
Gemfibrozil—Mental disorder—Carmustine—melanoma	0.000859	0.00393	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Temozolomide—melanoma	0.000854	0.00391	CcSEcCtD
Gemfibrozil—Cough—Bleomycin—melanoma	0.000853	0.00391	CcSEcCtD
Gemfibrozil—Anaemia—Dactinomycin—melanoma	0.000843	0.00386	CcSEcCtD
Gemfibrozil—Liver function test abnormal—Docetaxel—melanoma	0.000841	0.00385	CcSEcCtD
Gemfibrozil—Vomiting—Vemurafenib—melanoma	0.000838	0.00384	CcSEcCtD
Gemfibrozil—Alopecia—Temozolomide—melanoma	0.000837	0.00383	CcSEcCtD
Gemfibrozil—Chest pain—Bleomycin—melanoma	0.000833	0.00381	CcSEcCtD
Gemfibrozil—Myalgia—Bleomycin—melanoma	0.000833	0.00381	CcSEcCtD
Gemfibrozil—Abdominal pain upper—Docetaxel—melanoma	0.000832	0.00381	CcSEcCtD
Gemfibrozil—Rash—Vemurafenib—melanoma	0.000831	0.0038	CcSEcCtD
Gemfibrozil—Mental disorder—Temozolomide—melanoma	0.00083	0.0038	CcSEcCtD
Gemfibrozil—Dermatitis—Vemurafenib—melanoma	0.00083	0.0038	CcSEcCtD
Gemfibrozil—Headache—Vemurafenib—melanoma	0.000825	0.00378	CcSEcCtD
Gemfibrozil—Breast disorder—Docetaxel—melanoma	0.000823	0.00377	CcSEcCtD
Gemfibrozil—Leukopenia—Dactinomycin—melanoma	0.000816	0.00374	CcSEcCtD
Gemfibrozil—Nasopharyngitis—Docetaxel—melanoma	0.000815	0.00373	CcSEcCtD
Gemfibrozil—Dysgeusia—Temozolomide—melanoma	0.000808	0.0037	CcSEcCtD
Gemfibrozil—Confusional state—Bleomycin—melanoma	0.000805	0.00368	CcSEcCtD
Gemfibrozil—Vision blurred—Carmustine—melanoma	0.000804	0.00368	CcSEcCtD
Gemfibrozil—Oedema—Bleomycin—melanoma	0.000798	0.00365	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Bleomycin—melanoma	0.000798	0.00365	CcSEcCtD
Gemfibrozil—Anaemia—Carmustine—melanoma	0.000789	0.00361	CcSEcCtD
Gemfibrozil—Nausea—Vemurafenib—melanoma	0.000782	0.00358	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Bleomycin—melanoma	0.000781	0.00358	CcSEcCtD
Gemfibrozil—Vision blurred—Temozolomide—melanoma	0.000777	0.00356	CcSEcCtD
Gemfibrozil—Myalgia—Dactinomycin—melanoma	0.000776	0.00356	CcSEcCtD
Gemfibrozil—Leukopenia—Carmustine—melanoma	0.000764	0.0035	CcSEcCtD
Gemfibrozil—Anaemia—Temozolomide—melanoma	0.000762	0.00349	CcSEcCtD
Gemfibrozil—Angioedema—Temozolomide—melanoma	0.000754	0.00345	CcSEcCtD
Gemfibrozil—Pancytopenia—Docetaxel—melanoma	0.000748	0.00342	CcSEcCtD
Gemfibrozil—Oedema—Dactinomycin—melanoma	0.000744	0.00341	CcSEcCtD
Gemfibrozil—Vertigo—Temozolomide—melanoma	0.000741	0.00339	CcSEcCtD
Gemfibrozil—Convulsion—Carmustine—melanoma	0.00074	0.00339	CcSEcCtD
Gemfibrozil—Leukopenia—Temozolomide—melanoma	0.000738	0.00338	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Dactinomycin—melanoma	0.000729	0.00334	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Bleomycin—melanoma	0.000727	0.00333	CcSEcCtD
Gemfibrozil—Chest pain—Carmustine—melanoma	0.000727	0.00333	CcSEcCtD
Gemfibrozil—Myalgia—Carmustine—melanoma	0.000727	0.00333	CcSEcCtD
Gemfibrozil—Cough—Temozolomide—melanoma	0.00072	0.0033	CcSEcCtD
Gemfibrozil—Paraesthesia—Bleomycin—melanoma	0.000717	0.00328	CcSEcCtD
Gemfibrozil—Convulsion—Temozolomide—melanoma	0.000715	0.00327	CcSEcCtD
Gemfibrozil—Weight decreased—Docetaxel—melanoma	0.000712	0.00326	CcSEcCtD
Gemfibrozil—Confusional state—Carmustine—melanoma	0.000702	0.00322	CcSEcCtD
Gemfibrozil—Arthralgia—Temozolomide—melanoma	0.000702	0.00322	CcSEcCtD
Gemfibrozil—Myalgia—Temozolomide—melanoma	0.000702	0.00322	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000697	0.00319	CcSEcCtD
Gemfibrozil—Oedema—Carmustine—melanoma	0.000697	0.00319	CcSEcCtD
Gemfibrozil—Renal failure—Docetaxel—melanoma	0.00069	0.00316	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Docetaxel—melanoma	0.000688	0.00315	CcSEcCtD
Gemfibrozil—Jaundice—Docetaxel—melanoma	0.000684	0.00313	CcSEcCtD
Gemfibrozil—Pain—Bleomycin—melanoma	0.000682	0.00312	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Carmustine—melanoma	0.000682	0.00312	CcSEcCtD
Gemfibrozil—Confusional state—Temozolomide—melanoma	0.000679	0.00311	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000678	0.00311	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Temozolomide—melanoma	0.000673	0.00308	CcSEcCtD
Gemfibrozil—Oedema—Temozolomide—melanoma	0.000673	0.00308	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Docetaxel—melanoma	0.000664	0.00304	CcSEcCtD
Gemfibrozil—Nervous system disorder—Temozolomide—melanoma	0.00066	0.00302	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Temozolomide—melanoma	0.000659	0.00302	CcSEcCtD
Gemfibrozil—Feeling abnormal—Bleomycin—melanoma	0.000658	0.00301	CcSEcCtD
Gemfibrozil—Skin disorder—Temozolomide—melanoma	0.000654	0.00299	CcSEcCtD
Gemfibrozil—Fatigue—Dactinomycin—melanoma	0.000642	0.00294	CcSEcCtD
Gemfibrozil—Pain—Dactinomycin—melanoma	0.000636	0.00291	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Carmustine—melanoma	0.000635	0.00291	CcSEcCtD
Gemfibrozil—Urticaria—Bleomycin—melanoma	0.000634	0.0029	CcSEcCtD
Gemfibrozil—Rhinitis—Docetaxel—melanoma	0.000632	0.00289	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Docetaxel—melanoma	0.000627	0.00287	CcSEcCtD
Gemfibrozil—Paraesthesia—Carmustine—melanoma	0.000626	0.00286	CcSEcCtD
Gemfibrozil—Somnolence—Carmustine—melanoma	0.000619	0.00284	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Docetaxel—melanoma	0.000619	0.00284	CcSEcCtD
Gemfibrozil—Feeling abnormal—Dactinomycin—melanoma	0.000613	0.00281	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Temozolomide—melanoma	0.000613	0.00281	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Dactinomycin—melanoma	0.000609	0.00279	CcSEcCtD
Gemfibrozil—Paraesthesia—Temozolomide—melanoma	0.000605	0.00277	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Carmustine—melanoma	0.000601	0.00275	CcSEcCtD
Gemfibrozil—Somnolence—Temozolomide—melanoma	0.000598	0.00274	CcSEcCtD
Gemfibrozil—Pain—Carmustine—melanoma	0.000596	0.00273	CcSEcCtD
Gemfibrozil—Constipation—Carmustine—melanoma	0.000596	0.00273	CcSEcCtD
Gemfibrozil—Dyspepsia—Temozolomide—melanoma	0.000593	0.00271	CcSEcCtD
Gemfibrozil—Eye disorder—Docetaxel—melanoma	0.000589	0.0027	CcSEcCtD
Gemfibrozil—Abdominal pain—Dactinomycin—melanoma	0.000588	0.00269	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Temozolomide—melanoma	0.000581	0.00266	CcSEcCtD
Gemfibrozil—Fatigue—Temozolomide—melanoma	0.00058	0.00266	CcSEcCtD
Gemfibrozil—Pain—Temozolomide—melanoma	0.000576	0.00264	CcSEcCtD
Gemfibrozil—Constipation—Temozolomide—melanoma	0.000576	0.00264	CcSEcCtD
Gemfibrozil—Feeling abnormal—Carmustine—melanoma	0.000574	0.00263	CcSEcCtD
Gemfibrozil—Asthenia—Bleomycin—melanoma	0.000573	0.00262	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Carmustine—melanoma	0.00057	0.00261	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Docetaxel—melanoma	0.000568	0.0026	CcSEcCtD
Gemfibrozil—Pruritus—Bleomycin—melanoma	0.000565	0.00259	CcSEcCtD
Gemfibrozil—Alopecia—Docetaxel—melanoma	0.000557	0.00255	CcSEcCtD
Gemfibrozil—Feeling abnormal—Temozolomide—melanoma	0.000555	0.00254	CcSEcCtD
Gemfibrozil—Mental disorder—Docetaxel—melanoma	0.000552	0.00253	CcSEcCtD
Gemfibrozil—Abdominal pain—Carmustine—melanoma	0.000551	0.00252	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Temozolomide—melanoma	0.000551	0.00252	CcSEcCtD
Gemfibrozil—Dysgeusia—Docetaxel—melanoma	0.000537	0.00246	CcSEcCtD
Gemfibrozil—Urticaria—Temozolomide—melanoma	0.000535	0.00245	CcSEcCtD
Gemfibrozil—Asthenia—Dactinomycin—melanoma	0.000534	0.00245	CcSEcCtD
Gemfibrozil—Abdominal pain—Temozolomide—melanoma	0.000532	0.00244	CcSEcCtD
Gemfibrozil—Diarrhoea—Dactinomycin—melanoma	0.000509	0.00233	CcSEcCtD
Gemfibrozil—Vomiting—Bleomycin—melanoma	0.000507	0.00232	CcSEcCtD
Gemfibrozil—Anaemia—Docetaxel—melanoma	0.000507	0.00232	CcSEcCtD
Gemfibrozil—Rash—Bleomycin—melanoma	0.000503	0.0023	CcSEcCtD
Gemfibrozil—Dermatitis—Bleomycin—melanoma	0.000503	0.0023	CcSEcCtD
Gemfibrozil—Asthenia—Carmustine—melanoma	0.0005	0.00229	CcSEcCtD
Gemfibrozil—Syncope—Docetaxel—melanoma	0.000492	0.00225	CcSEcCtD
Gemfibrozil—Leukopenia—Docetaxel—melanoma	0.000491	0.00225	CcSEcCtD
Gemfibrozil—Asthenia—Temozolomide—melanoma	0.000483	0.00221	CcSEcCtD
Gemfibrozil—Loss of consciousness—Docetaxel—melanoma	0.000482	0.00221	CcSEcCtD
Gemfibrozil—Cough—Docetaxel—melanoma	0.000479	0.00219	CcSEcCtD
Gemfibrozil—Diarrhoea—Carmustine—melanoma	0.000477	0.00218	CcSEcCtD
Gemfibrozil—Pruritus—Temozolomide—melanoma	0.000476	0.00218	CcSEcCtD
Gemfibrozil—Convulsion—Docetaxel—melanoma	0.000475	0.00218	CcSEcCtD
Gemfibrozil—Nausea—Bleomycin—melanoma	0.000474	0.00217	CcSEcCtD
Gemfibrozil—Vomiting—Dactinomycin—melanoma	0.000473	0.00217	CcSEcCtD
Gemfibrozil—Rash—Dactinomycin—melanoma	0.000469	0.00215	CcSEcCtD
Gemfibrozil—Chest pain—Docetaxel—melanoma	0.000467	0.00214	CcSEcCtD
Gemfibrozil—Myalgia—Docetaxel—melanoma	0.000467	0.00214	CcSEcCtD
Gemfibrozil—Arthralgia—Docetaxel—melanoma	0.000467	0.00214	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000464	0.00212	CcSEcCtD
Gemfibrozil—Dizziness—Carmustine—melanoma	0.000461	0.00211	CcSEcCtD
Gemfibrozil—Diarrhoea—Temozolomide—melanoma	0.000461	0.00211	CcSEcCtD
Gemfibrozil—Confusional state—Docetaxel—melanoma	0.000451	0.00207	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Docetaxel—melanoma	0.000448	0.00205	CcSEcCtD
Gemfibrozil—Oedema—Docetaxel—melanoma	0.000448	0.00205	CcSEcCtD
Gemfibrozil—Dizziness—Temozolomide—melanoma	0.000445	0.00204	CcSEcCtD
Gemfibrozil—Vomiting—Carmustine—melanoma	0.000443	0.00203	CcSEcCtD
Gemfibrozil—Nausea—Dactinomycin—melanoma	0.000442	0.00202	CcSEcCtD
Gemfibrozil—Shock—Docetaxel—melanoma	0.00044	0.00202	CcSEcCtD
Gemfibrozil—Rash—Carmustine—melanoma	0.000439	0.00201	CcSEcCtD
Gemfibrozil—Nervous system disorder—Docetaxel—melanoma	0.000439	0.00201	CcSEcCtD
Gemfibrozil—Dermatitis—Carmustine—melanoma	0.000439	0.00201	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Docetaxel—melanoma	0.000438	0.00201	CcSEcCtD
Gemfibrozil—Headache—Carmustine—melanoma	0.000436	0.002	CcSEcCtD
Gemfibrozil—Skin disorder—Docetaxel—melanoma	0.000435	0.00199	CcSEcCtD
Gemfibrozil—Vomiting—Temozolomide—melanoma	0.000428	0.00196	CcSEcCtD
Gemfibrozil—Rash—Temozolomide—melanoma	0.000424	0.00194	CcSEcCtD
Gemfibrozil—Dermatitis—Temozolomide—melanoma	0.000424	0.00194	CcSEcCtD
Gemfibrozil—Headache—Temozolomide—melanoma	0.000422	0.00193	CcSEcCtD
Gemfibrozil—Nausea—Carmustine—melanoma	0.000414	0.00189	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Docetaxel—melanoma	0.000408	0.00187	CcSEcCtD
Gemfibrozil—Paraesthesia—Docetaxel—melanoma	0.000402	0.00184	CcSEcCtD
Gemfibrozil—Nausea—Temozolomide—melanoma	0.0004	0.00183	CcSEcCtD
Gemfibrozil—Somnolence—Docetaxel—melanoma	0.000398	0.00182	CcSEcCtD
Gemfibrozil—Dyspepsia—Docetaxel—melanoma	0.000394	0.0018	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Docetaxel—melanoma	0.000387	0.00177	CcSEcCtD
Gemfibrozil—Fatigue—Docetaxel—melanoma	0.000386	0.00177	CcSEcCtD
Gemfibrozil—Pain—Docetaxel—melanoma	0.000383	0.00175	CcSEcCtD
Gemfibrozil—Constipation—Docetaxel—melanoma	0.000383	0.00175	CcSEcCtD
Gemfibrozil—Feeling abnormal—Docetaxel—melanoma	0.000369	0.00169	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Docetaxel—melanoma	0.000366	0.00168	CcSEcCtD
Gemfibrozil—Abdominal pain—Docetaxel—melanoma	0.000354	0.00162	CcSEcCtD
Gemfibrozil—Asthenia—Docetaxel—melanoma	0.000321	0.00147	CcSEcCtD
Gemfibrozil—Pruritus—Docetaxel—melanoma	0.000317	0.00145	CcSEcCtD
Gemfibrozil—Diarrhoea—Docetaxel—melanoma	0.000306	0.0014	CcSEcCtD
Gemfibrozil—Dizziness—Docetaxel—melanoma	0.000296	0.00136	CcSEcCtD
Gemfibrozil—Vomiting—Docetaxel—melanoma	0.000285	0.0013	CcSEcCtD
Gemfibrozil—Rash—Docetaxel—melanoma	0.000282	0.00129	CcSEcCtD
Gemfibrozil—Dermatitis—Docetaxel—melanoma	0.000282	0.00129	CcSEcCtD
Gemfibrozil—Headache—Docetaxel—melanoma	0.00028	0.00128	CcSEcCtD
Gemfibrozil—Nausea—Docetaxel—melanoma	0.000266	0.00122	CcSEcCtD
Gemfibrozil—CYP2C8—Metabolism—MTAP—melanoma	4.66e-05	0.000353	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—PPARG—melanoma	4.61e-05	0.000349	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	4.55e-05	0.000345	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PLCB4—melanoma	4.55e-05	0.000345	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—melanoma	4.54e-05	0.000344	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—FASN—melanoma	4.46e-05	0.000338	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	4.4e-05	0.000334	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—SLC6A11—melanoma	4.27e-05	0.000324	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PIP4K2A—melanoma	4.27e-05	0.000324	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ACER3—melanoma	4.24e-05	0.000322	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CYP17A1—melanoma	4.19e-05	0.000318	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—MTAP—melanoma	4.16e-05	0.000315	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PHGDH—melanoma	4.15e-05	0.000315	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—LUM—melanoma	4.15e-05	0.000315	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PLCB4—melanoma	4.15e-05	0.000314	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	4.13e-05	0.000314	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—melanoma	4.08e-05	0.00031	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—HPSE—melanoma	4.07e-05	0.000309	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—FASN—melanoma	4.07e-05	0.000309	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	4.06e-05	0.000308	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—HRAS—melanoma	4.03e-05	0.000306	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CUBN—melanoma	4e-05	0.000303	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—GNA11—melanoma	3.96e-05	0.0003	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—SLC6A11—melanoma	3.9e-05	0.000296	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PIP4K2A—melanoma	3.9e-05	0.000296	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.89e-05	0.000295	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—ALB—melanoma	3.88e-05	0.000294	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—UGT2B10—melanoma	3.88e-05	0.000294	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—FASN—melanoma	3.87e-05	0.000294	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—IL6—melanoma	3.86e-05	0.000293	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—SDHD—melanoma	3.86e-05	0.000293	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—BSG—melanoma	3.86e-05	0.000293	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CSPG4—melanoma	3.86e-05	0.000293	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—SLC5A5—melanoma	3.81e-05	0.000289	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—MTAP—melanoma	3.79e-05	0.000288	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	3.76e-05	0.000285	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GPAM—melanoma	3.74e-05	0.000283	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PIK3CG—melanoma	3.71e-05	0.000281	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—LUM—melanoma	3.71e-05	0.000281	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PHGDH—melanoma	3.71e-05	0.000281	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	3.71e-05	0.000281	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—GNAQ—melanoma	3.68e-05	0.000279	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CD44—melanoma	3.68e-05	0.000279	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—HPSE—melanoma	3.63e-05	0.000276	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—HS3ST5—melanoma	3.61e-05	0.000274	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.6e-05	0.000273	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PPARG—melanoma	3.58e-05	0.000272	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.57e-05	0.000271	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CUBN—melanoma	3.57e-05	0.000271	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—AKT1—melanoma	3.56e-05	0.00027	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PLCB4—melanoma	3.54e-05	0.000269	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CYP1B1—melanoma	3.53e-05	0.000268	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—FASN—melanoma	3.48e-05	0.000264	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—BSG—melanoma	3.45e-05	0.000261	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CSPG4—melanoma	3.45e-05	0.000261	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—SDHD—melanoma	3.45e-05	0.000261	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PHGDH—melanoma	3.38e-05	0.000256	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—LUM—melanoma	3.38e-05	0.000256	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GPAM—melanoma	3.34e-05	0.000253	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PIP4K2A—melanoma	3.33e-05	0.000253	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—SLC6A11—melanoma	3.33e-05	0.000253	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—HPSE—melanoma	3.31e-05	0.000251	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PIK3CD—melanoma	3.26e-05	0.000247	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CUBN—melanoma	3.25e-05	0.000247	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—MTAP—melanoma	3.24e-05	0.000246	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—ALB—melanoma	3.22e-05	0.000244	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PLA2G6—melanoma	3.18e-05	0.000241	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	3.17e-05	0.00024	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—SDHD—melanoma	3.14e-05	0.000238	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—BSG—melanoma	3.14e-05	0.000238	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CSPG4—melanoma	3.14e-05	0.000238	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.11e-05	0.000236	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GPAM—melanoma	3.04e-05	0.000231	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—ABCB1—melanoma	2.91e-05	0.00022	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—LUM—melanoma	2.89e-05	0.000219	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PHGDH—melanoma	2.89e-05	0.000219	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—VCAN—melanoma	2.86e-05	0.000217	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PIK3CB—melanoma	2.84e-05	0.000216	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PLA2G6—melanoma	2.84e-05	0.000215	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—HPSE—melanoma	2.83e-05	0.000215	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PTGS2—melanoma	2.82e-05	0.000214	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CUBN—melanoma	2.78e-05	0.000211	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PLCB4—melanoma	2.73e-05	0.000207	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.7e-05	0.000205	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—MAPK3—melanoma	2.7e-05	0.000205	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—SDHD—melanoma	2.68e-05	0.000204	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—BSG—melanoma	2.68e-05	0.000204	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CSPG4—melanoma	2.68e-05	0.000204	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PRKCA—melanoma	2.67e-05	0.000203	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—ERCC2—melanoma	2.65e-05	0.000201	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—MYC—melanoma	2.63e-05	0.000199	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.61e-05	0.000198	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GPAM—melanoma	2.6e-05	0.000197	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PLA2G6—melanoma	2.59e-05	0.000196	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PIP4K2A—melanoma	2.57e-05	0.000195	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—SLC6A11—melanoma	2.57e-05	0.000195	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—VCAN—melanoma	2.55e-05	0.000193	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—MTAP—melanoma	2.5e-05	0.00019	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PTEN—melanoma	2.46e-05	0.000186	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.41e-05	0.000183	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CYP17A1—melanoma	2.41e-05	0.000183	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.38e-05	0.00018	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	2.35e-05	0.000178	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.33e-05	0.000177	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—VCAN—melanoma	2.32e-05	0.000176	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GNA11—melanoma	2.27e-05	0.000173	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—LUM—melanoma	2.23e-05	0.000169	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PHGDH—melanoma	2.23e-05	0.000169	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—FASN—melanoma	2.23e-05	0.000169	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PLA2G6—melanoma	2.21e-05	0.000168	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.2e-05	0.000167	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.2e-05	0.000167	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—SLC5A5—melanoma	2.19e-05	0.000166	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—HPSE—melanoma	2.19e-05	0.000166	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CYP17A1—melanoma	2.15e-05	0.000163	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CUBN—melanoma	2.15e-05	0.000163	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.12e-05	0.000161	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.12e-05	0.000161	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GNAQ—melanoma	2.11e-05	0.00016	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CD44—melanoma	2.11e-05	0.00016	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PIK3CG—melanoma	2.09e-05	0.000159	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	2.09e-05	0.000159	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CSPG4—melanoma	2.07e-05	0.000157	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—BSG—melanoma	2.07e-05	0.000157	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—SDHD—melanoma	2.07e-05	0.000157	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.07e-05	0.000157	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.05e-05	0.000156	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GNA11—melanoma	2.03e-05	0.000154	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CYP1B1—melanoma	2.03e-05	0.000154	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PPARG—melanoma	2.02e-05	0.000153	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GPAM—melanoma	2.01e-05	0.000152	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—FASN—melanoma	1.99e-05	0.000151	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—VCAN—melanoma	1.99e-05	0.000151	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYP17A1—melanoma	1.96e-05	0.000149	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—SLC5A5—melanoma	1.95e-05	0.000148	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.93e-05	0.000147	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	1.91e-05	0.000145	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GNAQ—melanoma	1.89e-05	0.000143	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CD44—melanoma	1.89e-05	0.000143	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.88e-05	0.000143	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GNA11—melanoma	1.85e-05	0.00014	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.85e-05	0.00014	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PIK3CD—melanoma	1.84e-05	0.00014	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.83e-05	0.000139	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—AKT1—melanoma	1.82e-05	0.000138	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—ALB—melanoma	1.82e-05	0.000138	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.81e-05	0.000138	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—FASN—melanoma	1.81e-05	0.000137	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CYP1B1—melanoma	1.81e-05	0.000137	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.79e-05	0.000136	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—SLC5A5—melanoma	1.78e-05	0.000135	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PIK3CA—melanoma	1.73e-05	0.000131	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GNAQ—melanoma	1.72e-05	0.000131	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CD44—melanoma	1.72e-05	0.000131	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PLA2G6—melanoma	1.71e-05	0.000129	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.69e-05	0.000128	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYP17A1—melanoma	1.68e-05	0.000127	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.67e-05	0.000127	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ABCB1—melanoma	1.67e-05	0.000127	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.65e-05	0.000125	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYP1B1—melanoma	1.65e-05	0.000125	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	1.63e-05	0.000124	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PIK3CB—melanoma	1.6e-05	0.000122	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.6e-05	0.000121	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PTGS2—melanoma	1.59e-05	0.000121	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GNA11—melanoma	1.58e-05	0.00012	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—FASN—melanoma	1.55e-05	0.000117	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PRKCA—melanoma	1.54e-05	0.000117	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—VCAN—melanoma	1.53e-05	0.000116	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ERCC2—melanoma	1.52e-05	0.000116	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—SLC5A5—melanoma	1.52e-05	0.000115	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ABCB1—melanoma	1.49e-05	0.000113	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GNAQ—melanoma	1.47e-05	0.000112	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CD44—melanoma	1.47e-05	0.000112	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.46e-05	0.00011	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.44e-05	0.000109	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.43e-05	0.000108	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—AKT1—melanoma	1.42e-05	0.000107	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYP1B1—melanoma	1.41e-05	0.000107	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PTEN—melanoma	1.39e-05	0.000105	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PRKCA—melanoma	1.37e-05	0.000104	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ERCC2—melanoma	1.36e-05	0.000103	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ABCB1—melanoma	1.36e-05	0.000103	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYP17A1—melanoma	1.29e-05	9.81e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.26e-05	9.57e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PRKCA—melanoma	1.25e-05	9.48e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.24e-05	9.44e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ERCC2—melanoma	1.24e-05	9.41e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GNA11—melanoma	1.22e-05	9.26e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PIK3CG—melanoma	1.2e-05	9.13e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—FASN—melanoma	1.19e-05	9.06e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—SLC5A5—melanoma	1.18e-05	8.91e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PPARG—melanoma	1.16e-05	8.81e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ABCB1—melanoma	1.16e-05	8.81e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GNAQ—melanoma	1.14e-05	8.61e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CD44—melanoma	1.14e-05	8.61e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.13e-05	8.55e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYP1B1—melanoma	1.09e-05	8.25e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PIK3CG—melanoma	1.07e-05	8.15e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PRKCA—melanoma	1.07e-05	8.1e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ERCC2—melanoma	1.06e-05	8.04e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PIK3CD—melanoma	1.06e-05	8.02e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ALB—melanoma	1.04e-05	7.92e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PPARG—melanoma	1.04e-05	7.86e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.03e-05	7.79e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PIK3CG—melanoma	9.8e-06	7.43e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PIK3CA—melanoma	9.78e-06	7.42e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PPARG—melanoma	9.45e-06	7.17e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PIK3CD—melanoma	9.44e-06	7.16e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ALB—melanoma	9.32e-06	7.07e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PIK3CB—melanoma	9.22e-06	6.99e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PTGS2—melanoma	9.14e-06	6.93e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ABCB1—melanoma	8.96e-06	6.8e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	8.78e-06	6.66e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PIK3CD—melanoma	8.61e-06	6.53e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ALB—melanoma	8.5e-06	6.45e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PIK3CG—melanoma	8.37e-06	6.35e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PRKCA—melanoma	8.25e-06	6.25e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PIK3CB—melanoma	8.23e-06	6.24e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ERCC2—melanoma	8.18e-06	6.2e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PTGS2—melanoma	8.16e-06	6.19e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PPARG—melanoma	8.08e-06	6.13e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—AKT1—melanoma	7.99e-06	6.06e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PTEN—melanoma	7.97e-06	6.04e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PIK3CB—melanoma	7.51e-06	5.69e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PTGS2—melanoma	7.44e-06	5.64e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PIK3CD—melanoma	7.36e-06	5.58e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ALB—melanoma	7.26e-06	5.51e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PTEN—melanoma	7.11e-06	5.39e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PTEN—melanoma	6.49e-06	4.92e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PIK3CG—melanoma	6.46e-06	4.9e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PIK3CB—melanoma	6.41e-06	4.86e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PTGS2—melanoma	6.36e-06	4.82e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PPARG—melanoma	6.24e-06	4.73e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PIK3CD—melanoma	5.68e-06	4.31e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PIK3CA—melanoma	5.62e-06	4.26e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ALB—melanoma	5.61e-06	4.25e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PTEN—melanoma	5.54e-06	4.2e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PIK3CA—melanoma	5.02e-06	3.81e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PIK3CB—melanoma	4.95e-06	3.75e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PTGS2—melanoma	4.9e-06	3.72e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—AKT1—melanoma	4.59e-06	3.48e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PIK3CA—melanoma	4.58e-06	3.47e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PTEN—melanoma	4.28e-06	3.24e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—AKT1—melanoma	4.1e-06	3.11e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PIK3CA—melanoma	3.91e-06	2.97e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—AKT1—melanoma	3.74e-06	2.83e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—AKT1—melanoma	3.19e-06	2.42e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PIK3CA—melanoma	3.02e-06	2.29e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—AKT1—melanoma	2.47e-06	1.87e-05	CbGpPWpGaD
